top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
MERS-CoV
MERS-CoV
Autore Du Lanying
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 online resource (274 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato animal model
animal models
authentic virus
camels
cell-cell fusion
combination
complement
Coronavirus
coronavirus spike glycoprotein
coronaviruses
correlates of immunity
cross-neutralization
DPP4
Drivers
fusion inhibitor
HCoV-229E
hDPP4
HKU4
host factors
inflammation
lipidomics
mechanism of action
MERS-coronavirus
MERS-CoV
MERS-CoV nucleocapsid protein
Middle East respiratory syndrome coronavirus
Middle East Respiratory Syndrome Virus
mouse model
murine CD8+ T cell epitope
mutation
MVA vaccine
n/a
nanobodies
neutralizing antibody
neutralizing monoclonal antibodies
One Health
pathogenesis
peptide
prevention and treatment
pseudotyped virus
pyroptosis
Qatar
rabbits
RBD
receptor-binding domain
SARS-CoV
severe acute respiratory syndrome coronavirus
small-molecule inhibitor
spike protein
spike proteins
therapeutic antibodies
therapeutics
transmission
UHPLC-MS
vaccine platforms
vaccines
ISBN 3-03921-851-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367737603321
Du Lanying  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances in Antibody Therapeutics
Recent Advances in Antibody Therapeutics
Autore Heo Yong-Seok
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (238 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato affinity maturation
agonist antibody
anti-angiogenesis
anti-cancer antibody
antibodies
antibody
antibody engineering
antibody therapeutics
antibody therapy
antibody-drug conjugates
antigen
asthma
atherosclerosis
binding assays
bioassays
biochemical and physicochemical properties
biomarker
biophysical properties
bispecific antibodies
bladder cancer
blood-brain barrier
brain shuttle
C2_2E12
cell fate
combinatorial antibody library
computational methods
cost-effectiveness
cytomegalovirus
delta-like ligand
disposition
enfortumab vedotin
erdafitinib
Fc binding
G protein-coupled receptor
HPV cancer therapy
HPV oncoproteins
HPV-associated cancer
Human papillomaviruses
immune checkpoint inhibitors
inflammation
interleukin 33
intracellular antibodies
irinotecan
mechanisms of action
membrane protein
molecular Trojan horse
monoclonal antibody
n/a
nanobody
paclitaxel
peptide/major histocompatibility complex class I complex
phage display
pharmacokinetics
potency assays
receptor-binding domain
receptor-mediated transcytosis
recombinant antibodies
refractory asthma
research cell bank
sacituzumab govitecan
SARS-CoV-2
scFv
single-chain antibody fragment
spike protein
ST2 receptor
T-cell-receptor-like antibody
therapeutic antibody
transferrin
VEGF
yeast surface display
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580204803321
Heo Yong-Seok  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui